Cyclacel Pharmaceuticals (CYCC) News Today → Automatic Income (from home) (From Awesomely, LLC) (Ad) Free CYCC Stock Alerts $2.00 -0.49 (-19.68%) (As of 05/3/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCyclacel Pharmaceuticals Announces Closing of $8.0 Million Private Placement Priced At-The-Market Under NASDAQ Rulesglobenewswire.com - May 2 at 4:30 PMCyclacel Pharmaceuticals (NASDAQ:CYCC) Now Covered by StockNews.comamericanbankingnews.com - May 2 at 5:24 AMWhy Is Cyclacel Pharmaceuticals (CYCC) Stock Up 46% Today?msn.com - April 30 at 7:57 AMWhy Is Cyclacel Pharmaceuticals (CYCC) Stock Up 46% Today?investorplace.com - April 30 at 7:47 AMCyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under Nasdaq Rulesglobenewswire.com - April 30 at 7:00 AMCyclacel Pharmaceuticals Shares Up 72% After Hours on Withdrawal of Offeringmarketwatch.com - April 29 at 9:57 PMCyclacel Pharmaceuticals Shares Hit All-Time Low on Planned Equity Salemarketwatch.com - April 26 at 7:08 AMCyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Is Expected To Breakeven In The Near Futurefinance.yahoo.com - April 25 at 9:41 AMCyclacel Pharmaceuticals (NASDAQ:CYCC) Receives New Coverage from Analysts at StockNews.comamericanbankingnews.com - April 24 at 2:38 AMCyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib's Potential as a Precision Medicine for Cancerglobenewswire.com - April 1 at 9:15 AMCyclacel Pharmaceuticals Incmoney.usnews.com - March 27 at 4:39 AMCyclacel Pharmaceuticals, Inc. (CYCC) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 21 at 3:27 AMCyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 20 at 12:21 PMCYCC Stock Earnings: Cyclacel Pharmaceuticals Misses EPS for Q4 2023msn.com - March 19 at 9:26 PMCyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updateglobenewswire.com - March 19 at 4:05 PMCyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial Resultsglobenewswire.com - March 13 at 4:05 PMCyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024globenewswire.com - March 7 at 9:15 AMCyclacel Pharmaceuticals Announces Receipt of $2.9 Million R&D Tax Creditglobenewswire.com - March 6 at 9:15 AMCyclacel Pharmaceuticals, Inc. (CYCCP)finance.yahoo.com - February 22 at 2:10 PMCyclacel Pharmaceuticals to Participate in 2024 BIO CEO & Investor Conferenceglobenewswire.com - February 20 at 9:15 AMCyclacel Pharmaceuticals Inc. (UXI.SG)finance.yahoo.com - February 15 at 7:46 AMCyclacel Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirementfinance.yahoo.com - January 8 at 10:11 AMWhy Cyclacel Pharmaceuticals (CYCC) Shares Are Getting Obliteratedmsn.com - December 22 at 12:40 PMCyclacel Pharmaceuticals Announces Registered Direct and Private Placement Offering Priced At-The-Market Under Nasdaq Rulesfinance.yahoo.com - December 22 at 12:40 PMmarketbeat.com - December 22 at 9:36 AMBrookline Capital Downgrades Cyclacel Pharmaceuticals (CYCC)msn.com - December 20 at 7:42 AMmarketbeat.com - December 18 at 6:05 AMCyclacel Pharmaceuticals Stock (NASDAQ:CYCC) Dividends: History, Yield and Datesbenzinga.com - December 15 at 10:32 PMCyclacel Pharmaceuticals Announces Reverse Stock Splitfinance.yahoo.com - December 12 at 5:42 PMCyclacel Pharmaceuticals regains compliance with Nasdaq listing rulesmsn.com - November 30 at 12:09 PMCyclacel Receives Notification of Deficiency From Nasdaq Regarding Timely Filing of Quarterly Report on Form 10-Qbenzinga.com - November 28 at 6:36 PMCyclacel Receives Notification of Deficiency From Nasdaq Regarding Timely Filing of Quarterly Report on Form 10-Qfinance.yahoo.com - November 28 at 6:36 PMCyclacel Pharmaceuticals (CYCC) Price Target Increased by 11.56% to 13.94msn.com - November 27 at 8:27 PMCyclacel Pharmaceuticals Inc CYCCmorningstar.com - November 24 at 11:17 PMCyclacel Pharmaceuticals, Inc. PFD CONV EX 6% goes ex dividend tomorrowmsn.com - October 19 at 1:04 PMCyclacel Pharmaceuticals GAAP EPS of -$0.44 beats by $0.06, revenue of $0.37Mmsn.com - August 9 at 5:54 PMCyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Updatefinance.yahoo.com - August 9 at 5:54 PMCyclacel Pharmaceuticals to Release Second Quarter 2023 Financial Resultsfinance.yahoo.com - August 3 at 9:54 AMCyclacel Pharmaceuticals, Inc. (CYCC) Upgraded to Strong Buy: Here's Whyfinance.yahoo.com - July 13 at 4:04 PMJointown Pharmaceutical Groupforbes.com - June 15 at 11:20 PMOppenheimer Maintains Cyclacel Pharmaceuticals (CYCC) Outperform Recommendationmsn.com - May 26 at 3:44 AMCyclacel Pharmaceuticals Announces Receipt of $4.7 Million R&D Tax Creditfinance.yahoo.com - May 3 at 10:29 AMCyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q4 2022 Earnings Call Transcriptfinance.yahoo.com - March 8 at 11:56 PMOppenheimer Maintains Outperform Rating for Cyclacel Pharmaceuticals: Here's What You Need To Knowmsn.com - March 7 at 4:36 PMA Preview Of Cyclacel Pharmaceuticals's Earningsmsn.com - March 3 at 3:29 PMCyclacel Pharmaceuticals to Participate in the 2023 BIO CEO & Investor Conferencefinance.yahoo.com - January 30 at 10:58 AMCyclacel Pharmaceuticals to Present at Biotech Showcase and Participate in a Corporate Access Event During the J.P. Morgan Healthcare Conference in January 2023finance.yahoo.com - December 15 at 12:47 PMCyclacel Pharmaceuticals, Inc. (CYCC) Q3 2022 Earnings Call Transcriptseekingalpha.com - November 9 at 8:56 PMEarnings Outlook For Cyclacel Pharmaceuticalsmsn.com - November 8 at 4:16 PMHere's What to Expect Ahead of Wix's (WIX) Q3 Earnings Releasefinance.yahoo.com - November 7 at 1:43 PM Get Cyclacel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CYCC and its competitors with MarketBeat's FREE daily newsletter. Email Address Automatic Income (from home) (Ad)For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year. Just click here now to watch my presentation for free. CYCC Media Mentions By Week CYCC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CYCC News Sentiment▼0.090.42▲Average Medical News Sentiment CYCC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CYCC Articles This Week▼70▲CYCC Articles Average Week Get Cyclacel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CYCC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Dermata Therapeutics News Today CNS Pharmaceuticals News Today Altamira Therapeutics News Today Notable Labs News Today Salarius Pharmaceuticals News Today CohBar News Today Onconetix News Today TransCode Therapeutics News Today Agile Therapeutics News Today Clearmind Medicine News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CYCC) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024AltimetryThe only AI company you should be looking atBehind the MarketsThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclacel Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
